1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,295 | 1,350 | 12:16 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MENTICE Aktie jetzt für 0€ handeln | |||||
| Mo | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | 94 | GlobeNewswire (Europe) | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| 07.05. | Mentice AB: Interim Report Jan-mar 2026 | 137 | GlobeNewswire (Europe) | CONTINUED MOMENTUM AND STRONG ORGANIC GROWTH
Significant events during the FIRST quarter 2026 (JAN - MAR)Order intake and revenues increased significantly during the quarter and Order Intake amounted... ► Artikel lesen | |
| 23.03. | Mentice AB: Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group | 123 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg, Sweden - Mentice today announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026. Rick brings extensive experience in financial management... ► Artikel lesen | |
| 26.02. | Mentice AB: Communique from extraordinary shareholders' meeting in Mentice AB | 124 | GlobeNewswire (Europe) | An extraordinary shareholders' meeting was held in Mentice AB ("the Company") on February 26, 2026. Below follows a summary of the resolutions made at the meeting.
Resolution on the number of board... ► Artikel lesen | |
| 26.02. | Mentice AB Reports Increase In Q4 Income | - | RTTNews | ||
| 26.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2025 | 143 | GlobeNewswire (Europe) | STRONG ORGANIC GROWTH AND RESULT IMPROVEMENT DESPITE CURRENCY HEADWINDS
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER 2025 (OCT - DEC)Order intake increased significantly during the quarter and amounted... ► Artikel lesen | |
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 368 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen | |
| 06.11.25 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2025 | 248 | GlobeNewswire (Europe) | SIGNIFICANT PROGRESS IN PERFORMANCE AS MARKET ACTIVITY INCREASES
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2025 (Jul - Sep)• The strategic organizational change announced in June, aimed at aligning... ► Artikel lesen | |
| 21.08.25 | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 243 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 01.08.25 | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 236 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 31.07.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 462 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 306 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 261 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen | |
| 11.07.25 | Mentice AB: Mentice AB Announces Consolidation of Physical Simulation Operations to Strengthen Long-Term Efficiency and Global Service Delivery | 452 | GlobeNewswire (Europe) | Gothenburg, Sweden, July 11, 2025 - Mentice AB (publ), a global leader in simulation solutions for image-guided therapies, today announces the decision to consolidate its research and development (R&D)... ► Artikel lesen | |
| 16.06.25 | Mentice AB: Mentice AB announces the intent for a strategic workforce realignment to enhance focus and operational efficiency and the intent for a rights issue of max 10% of the share capital | 305 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announces the intent of a strategic workforce realignment and the intent of planning... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,000 | -1,17 % | Eckert & Ziegler sichert sich Blei-212-Versorgung von Thor Medical | Die Eckert & Ziegler SE hat mit dem norwegischen Isotopen-Spezialisten Thor Medical eine Kooperations- und Liefervereinbarung für das Radioisotop Blei-212 abgeschlossen. Thor Medical wird zunächst Blei-212... ► Artikel lesen | |
| PENUMBRA | 274,80 | +0,15 % | Penumbra, Inc. Reports First Quarter 2026 Financial Results | ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,290 | -0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,00 | +0,03 % | BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable | ||
| FRESENIUS | 35,360 | -0,25 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| GENEDX | 52,00 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| QTREX QUANTUM | 3,100 | +0,65 % | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | ||
| BILLIONTOONE | 90,86 | -0,29 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,860 | 0,00 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 26,210 | +0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| HEARTFLOW | 30,950 | -0,16 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,170 | -0,63 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,665 | 0,00 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,320 | +0,18 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| ADAPTHEALTH | 9,910 | -0,20 % | AdaptHealth Corp. - 10-Q, Quarterly Report |
Das Unternehmen MENTICE AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,270 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MENTICE AB finden Sie auf Wallstreet Online.